Drug Screening Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Drug screening is a technical process, performed for analyzing specimens such as hair, urine, oral fluids, breath and other samples. Drug screening aids in detection of drug or a chemical compound in the body. This process is applied in hospitals, drug testing centers, pain management centers as well as law enforcement agencies. Drug screening tests are also performed by companies and organizations on employees and athletes to check for drug abuse.
MARKET SCOPE
The "Global Drug Screening Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the drug screening market with detailed market segmentation by type, products, Disease Detection, application, and geography. The report provides key statistics on the market status of the leading drug screening market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product type, the market is segmented as analytical instruments, rapid testing devices and consumables.
- On the basis of sample, the global drug screening market is segmented into breath, hair, oral fluid, urine and others.
- Based on end user, the market is bifurcated into drug testing laboratories, drug treatment centers, criminal justice systems & law enforcement agencies, pain management centers, hospitals, individuals and others
MARKET DYNAMICS
Drivers
- Increase consumption of alcohol and drugs during the previous years, has been a matter of concern for various employers.
- Various government bodies have been providing funds for drug screening tests.
- Development and adoption of new methods as well as devices for drug screening is anticipated to be the driving factors for the growth of drug screening market.
Restraints
- Bans on alcohol consumption in Islamic countries is likely to restraint the market growth.
- Prohibition of drug testing at workplace
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The drug screening market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the drug screening market in these regions.
IMPACT OF COVID-19 ON DRUG SCREENING MARKET
COVID-19 has ended in significant disruptions to businesses and commercial activities globally. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth. However, it is expected to have a short-term negative influence on the drug screening market due to the limited or non-availability of medical departments or treatment centers, harm-reducing service providers, and the fear of infection transmission. In addition, various authorities worldwide provided guidelines to postpone or delay non-essential medical and surgical systems to reduce the strain on the healthcare system and decrease disease transmission. Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Have a question?
Speak to Analyst
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The drug screening market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the drug screening market in these regions.
IMPACT OF COVID-19 ON DRUG SCREENING MARKET
COVID-19 has ended in significant disruptions to businesses and commercial activities globally. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth. However, it is expected to have a short-term negative influence on the drug screening market due to the limited or non-availability of medical departments or treatment centers, harm-reducing service providers, and the fear of infection transmission. In addition, various authorities worldwide provided guidelines to postpone or delay non-essential medical and surgical systems to reduce the strain on the healthcare system and decrease disease transmission.
MARKET PLAYERS
The report covers key developments in the drug screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from drug screening market are anticipated to lucrative growth opportunities in the future with the rising demand for drug screening in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the drug screening market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Abbott
- Omega Laboratories, Inc.
- Roche Monitoring Services.
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Premier Biotech, Inc.
- OraSure Technologies, Inc.
- Psychemedics Corporation
- Laboratory Corporation of America Holdings
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Screening Market - By Product Type
1.3.2 Drug Screening Market - By Sample Type
1.3.3 Drug Screening Market - By End User
1.3.4 Drug Screening Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG SCREENING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG SCREENING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG SCREENING MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG SCREENING - GLOBAL MARKET OVERVIEW
6.2. DRUG SCREENING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. DRUG SCREENING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANALYTICAL INSTRUMENTS
7.3.1. Overview
7.3.2. Analytical Instruments Market Forecast and Analysis
7.3.3. Immunoassay Analyzers Market
7.3.3.1. Overview
7.3.3.2. Immunoassay Analyzers Market Forecast and Analysis
7.3.4. Chromatography Instruments Market
7.3.4.1. Overview
7.3.4.2. Chromatography Instruments Market Forecast and Analysis
7.3.5. Breathalyzers Market
7.3.5.1. Overview
7.3.5.2. Breathalyzers Market Forecast and Analysis
7.4. RAPID TESTING DEVICES
7.4.1. Overview
7.4.2. Rapid Testing Devices Market Forecast and Analysis
7.4.3. Urine Testing Devices Market
7.4.3.1. Overview
7.4.3.2. Urine Testing Devices Market Forecast and Analysis
7.4.4. Oral Fluid Testing Devices Market
7.4.4.1. Overview
7.4.4.2. Oral Fluid Testing Devices Market Forecast and Analysis
7.5. CONSUMABLES
7.5.1. Overview
7.5.2. Consumables Market Forecast and Analysis
8. DRUG SCREENING MARKET - REVENUE AND FORECASTS TO 2028 - SAMPLE TYPE
8.1. OVERVIEW
8.2. SAMPLE TYPE MARKET FORECASTS AND ANALYSIS
8.3. BREATH
8.3.1. Overview
8.3.2. Breath Market Forecast and Analysis
8.4. HAIR
8.4.1. Overview
8.4.2. Hair Market Forecast and Analysis
8.5. ORAL FLUID
8.5.1. Overview
8.5.2. Oral Fluid Market Forecast and Analysis
8.6. URINE
8.6.1. Overview
8.6.2. Urine Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. DRUG SCREENING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. DRUG TESTING LABORATORIES
9.3.1. Overview
9.3.2. Drug Testing Laboratories Market Forecast and Analysis
9.4. DRUG TREATMENT CENTERS
9.4.1. Overview
9.4.2. Drug Treatment Centers Market Forecast and Analysis
9.5. PAIN MANAGEMENT CENTERS
9.5.1. Overview
9.5.2. Pain Management Centers Market Forecast and Analysis
9.6. CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES
9.6.1. Overview
9.6.2. Criminal Justice Systems and Law Enforcement Agencies Market Forecast and Analysis
9.7. HOSPITALS
9.7.1. Overview
9.7.2. Hospitals Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. DRUG SCREENING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Drug Screening Market Overview
10.1.2 North America Drug Screening Market Forecasts and Analysis
10.1.3 North America Drug Screening Market Forecasts and Analysis - By Product Type
10.1.4 North America Drug Screening Market Forecasts and Analysis - By Sample Type
10.1.5 North America Drug Screening Market Forecasts and Analysis - By End User
10.1.6 North America Drug Screening Market Forecasts and Analysis - By Countries
10.1.6.1 United States Drug Screening Market
10.1.6.1.1 United States Drug Screening Market by Product Type
10.1.6.1.2 United States Drug Screening Market by Sample Type
10.1.6.1.3 United States Drug Screening Market by End User
10.1.6.2 Canada Drug Screening Market
10.1.6.2.1 Canada Drug Screening Market by Product Type
10.1.6.2.2 Canada Drug Screening Market by Sample Type
10.1.6.2.3 Canada Drug Screening Market by End User
10.1.6.3 Mexico Drug Screening Market
10.1.6.3.1 Mexico Drug Screening Market by Product Type
10.1.6.3.2 Mexico Drug Screening Market by Sample Type
10.1.6.3.3 Mexico Drug Screening Market by End User
10.2. EUROPE
10.2.1 Europe Drug Screening Market Overview
10.2.2 Europe Drug Screening Market Forecasts and Analysis
10.2.3 Europe Drug Screening Market Forecasts and Analysis - By Product Type
10.2.4 Europe Drug Screening Market Forecasts and Analysis - By Sample Type
10.2.5 Europe Drug Screening Market Forecasts and Analysis - By End User
10.2.6 Europe Drug Screening Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Drug Screening Market
10.2.6.1.1 Germany Drug Screening Market by Product Type
10.2.6.1.2 Germany Drug Screening Market by Sample Type
10.2.6.1.3 Germany Drug Screening Market by End User
10.2.6.2 France Drug Screening Market
10.2.6.2.1 France Drug Screening Market by Product Type
10.2.6.2.2 France Drug Screening Market by Sample Type
10.2.6.2.3 France Drug Screening Market by End User
10.2.6.3 Italy Drug Screening Market
10.2.6.3.1 Italy Drug Screening Market by Product Type
10.2.6.3.2 Italy Drug Screening Market by Sample Type
10.2.6.3.3 Italy Drug Screening Market by End User
10.2.6.4 Spain Drug Screening Market
10.2.6.4.1 Spain Drug Screening Market by Product Type
10.2.6.4.2 Spain Drug Screening Market by Sample Type
10.2.6.4.3 Spain Drug Screening Market by End User
10.2.6.5 United Kingdom Drug Screening Market
10.2.6.5.1 United Kingdom Drug Screening Market by Product Type
10.2.6.5.2 United Kingdom Drug Screening Market by Sample Type
10.2.6.5.3 United Kingdom Drug Screening Market by End User
10.2.6.6 Rest of Europe Drug Screening Market
10.2.6.6.1 Rest of Europe Drug Screening Market by Product Type
10.2.6.6.2 Rest of Europe Drug Screening Market by Sample Type
10.2.6.6.3 Rest of Europe Drug Screening Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Drug Screening Market Overview
10.3.2 Asia-Pacific Drug Screening Market Forecasts and Analysis
10.3.3 Asia-Pacific Drug Screening Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Drug Screening Market Forecasts and Analysis - By Sample Type
10.3.5 Asia-Pacific Drug Screening Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Drug Screening Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Drug Screening Market
10.3.6.1.1 Australia Drug Screening Market by Product Type
10.3.6.1.2 Australia Drug Screening Market by Sample Type
10.3.6.1.3 Australia Drug Screening Market by End User
10.3.6.2 China Drug Screening Market
10.3.6.2.1 China Drug Screening Market by Product Type
10.3.6.2.2 China Drug Screening Market by Sample Type
10.3.6.2.3 China Drug Screening Market by End User
10.3.6.3 India Drug Screening Market
10.3.6.3.1 India Drug Screening Market by Product Type
10.3.6.3.2 India Drug Screening Market by Sample Type
10.3.6.3.3 India Drug Screening Market by End User
10.3.6.4 Japan Drug Screening Market
10.3.6.4.1 Japan Drug Screening Market by Product Type
10.3.6.4.2 Japan Drug Screening Market by Sample Type
10.3.6.4.3 Japan Drug Screening Market by End User
10.3.6.5 South Korea Drug Screening Market
10.3.6.5.1 South Korea Drug Screening Market by Product Type
10.3.6.5.2 South Korea Drug Screening Market by Sample Type
10.3.6.5.3 South Korea Drug Screening Market by End User
10.3.6.6 Rest of Asia-Pacific Drug Screening Market
10.3.6.6.1 Rest of Asia-Pacific Drug Screening Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Drug Screening Market by Sample Type
10.3.6.6.3 Rest of Asia-Pacific Drug Screening Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Drug Screening Market Overview
10.4.2 Middle East and Africa Drug Screening Market Forecasts and Analysis
10.4.3 Middle East and Africa Drug Screening Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Drug Screening Market Forecasts and Analysis - By Sample Type
10.4.5 Middle East and Africa Drug Screening Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Drug Screening Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Drug Screening Market
10.4.6.1.1 South Africa Drug Screening Market by Product Type
10.4.6.1.2 South Africa Drug Screening Market by Sample Type
10.4.6.1.3 South Africa Drug Screening Market by End User
10.4.6.2 Saudi Arabia Drug Screening Market
10.4.6.2.1 Saudi Arabia Drug Screening Market by Product Type
10.4.6.2.2 Saudi Arabia Drug Screening Market by Sample Type
10.4.6.2.3 Saudi Arabia Drug Screening Market by End User
10.4.6.3 U.A.E Drug Screening Market
10.4.6.3.1 U.A.E Drug Screening Market by Product Type
10.4.6.3.2 U.A.E Drug Screening Market by Sample Type
10.4.6.3.3 U.A.E Drug Screening Market by End User
10.4.6.4 Rest of Middle East and Africa Drug Screening Market
10.4.6.4.1 Rest of Middle East and Africa Drug Screening Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Drug Screening Market by Sample Type
10.4.6.4.3 Rest of Middle East and Africa Drug Screening Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Drug Screening Market Overview
10.5.2 South and Central America Drug Screening Market Forecasts and Analysis
10.5.3 South and Central America Drug Screening Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Drug Screening Market Forecasts and Analysis - By Sample Type
10.5.5 South and Central America Drug Screening Market Forecasts and Analysis - By End User
10.5.6 South and Central America Drug Screening Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Drug Screening Market
10.5.6.1.1 Brazil Drug Screening Market by Product Type
10.5.6.1.2 Brazil Drug Screening Market by Sample Type
10.5.6.1.3 Brazil Drug Screening Market by End User
10.5.6.2 Argentina Drug Screening Market
10.5.6.2.1 Argentina Drug Screening Market by Product Type
10.5.6.2.2 Argentina Drug Screening Market by Sample Type
10.5.6.2.3 Argentina Drug Screening Market by End User
10.5.6.3 Rest of South and Central America Drug Screening Market
10.5.6.3.1 Rest of South and Central America Drug Screening Market by Product Type
10.5.6.3.2 Rest of South and Central America Drug Screening Market by Sample Type
10.5.6.3.3 Rest of South and Central America Drug Screening Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG SCREENING MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. DRUG SCREENING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. OMEGA LABORATORIES, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. F. HOFFMANN-LA ROCHE LTD
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DR
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. THERMO FISHER SCIENTIFIC INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. QUEST DIAGNOSTICS INCORPORATED
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PREMIER BIOTECH, INC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORASURE TECHNOLOGIES, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PSYCHEMEDICS CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott
2. Omega Laboratories, Inc.
3. Roche Monitoring Services.
4. Siemens Healthcare GmbH
5. Thermo Fisher Scientific Inc.
6. Quest Diagnostics Incorporated
7. Premier Biotech, Inc.
8. OraSure Technologies, Inc.
9. Psychemedics Corporation
10. Laboratory Corporation of America Holdings
11. Alere, Inc
12. Drägerwerk AG & Co. KGAA
13. Biorad Laboratories, Inc.
14. Danaher Corporation
15. Express Diagnostics International Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For